SCHEMBL30820060

SCHEMBL30820060

Cc1ncc2ccccc2c1Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 2/20 0.47
KDM4E B2RXH2 1/20 0.47
CYP2A6 P11509 5/20 0.45
CYP1A2 P05177 4/20 0.42
POLB P06746 1/20 0.41
ALDH1A1 P00352 4/20 0.37
MAPT P10636 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TSHR P16473 2/20 0.34
TDP1 Q9NUW8 3/20 0.34
HSD17B10 Q99714 3/20 0.34
MAPK1 P28482 1/20 0.34
PARP1 P09874 1/20 0.34
PRKCI P41743 1/20 0.34
PDE4B Q07343 1/20 0.34
HPGD P15428 1/20 0.34
NUDT1 P36639 1/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL112386 1.00 GPR3 (0.47) GPR3KDM4ECYP2A6CYP1A2POLB
SCHEMBL16552260 0.78 KDM4E (0.50) GPR3KDM4ECYP2A6CYP1A2POLB
SCHEMBL12258315 0.78 GPR3 (0.50) GPR3KDM4ECYP2A6CYP1A2ALDH1A1
SCHEMBL30901311 0.78 KDM4E (0.50) GPR3KDM4ECYP2A6CYP1A2POLB
SCHEMBL17942817 0.77 KDM4E (0.48) GPR3KDM4ECYP2A6CYP1A2POLB
SCHEMBL25170252 0.75 KDM4E (0.47) GPR3KDM4ECYP2A6CYP1A2POLB
SCHEMBL15401178 0.75 KDM4E (0.47) GPR3KDM4ECYP1A2POLBALDH1A1
SCHEMBL7315366 0.75 POLB (0.50) GPR3KDM4ECYP2A6CYP1A2POLB
SCHEMBL28483779 0.75 KDM4E (0.47) GPR3KDM4ECYP2A6CYP1A2POLB
SCHEMBL16144709 0.75 GPR3 (0.47) GPR3KDM4ECYP2A6CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4605386-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-08-27 EP disclosed
WO-2024086111-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-04-25 WO disclosed